Richard Dillon

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung et al. · Nature Medicine · 2016 · 393 citations · Full text

Hematological Malignancy, Chromatin, Distinct Evolution +10

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without <i>NPM1</i> Mutations

Sylvie Freeman, Robert K. Hills, Paul Virgo et al. · Journal of Clinical Oncology · 2018 · 195 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +14

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Richard Dillon, Robert K. Hills, Sylvie Freeman et al. · Blood · 2020 · 160 citations · Full text

Unified classification and risk-stratification in Acute Myeloid Leukemia

Yanis Tazi, Juan E. Arango‐Ossa, Yangyu Zhou et al. · Nature Communications · 2022 · 159 citations · Full text